<DOC>
	<DOCNO>NCT02422654</DOCNO>
	<brief_summary>Primary Objective : The purpose study assess palatability eliglustat prototype liquid formulation healthy subject .</brief_summary>
	<brief_title>Taste Evaluation Different Liquid Formulations With Eliglustat</brief_title>
	<detailed_description>The total duration study subject approximately 5 week ( screen period Day -28 Day -2 , treatment period 3 day , follow-up call Day 5 ) .</detailed_description>
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Eliglustat</mesh_term>
	<criteria>Inclusion criterion : Healthy male female subject , 18 55 year age , inclusive . Normal smell taste ability discriminate odor flavor difference . Exclusion criterion : Poor metabolizer phenotype status CYP2D6 ( predict base genotype ) . Subject smoke within 3 month inclusion . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>